Correlating nuclear morphometric patterns with estrogen receptor status in breast cancer pathologic specimens

[1]  Andrew H. Beck,et al.  Systematic Analysis of Breast Cancer Morphology Uncovers Stromal Features Associated with Survival , 2011, Science Translational Medicine.

[2]  Clive R Taylor,et al.  Recommendations for Improved Standardization of Immunohistochemistry , 2007, Applied immunohistochemistry & molecular morphology : AIMM.

[3]  Janice Branson,et al.  Epigenetic Modification of the FMR1 Gene in Fragile X Syndrome Is Associated with Differential Response to the mGluR5 Antagonist AFQ056 , 2011, Science Translational Medicine.

[4]  D. Allred.  Issues and updates: evaluating estrogen receptor-α, progesterone receptor, and HER2 in breast cancer , 2010, Modern Pathology.

[5]  N. Robert.  Clinical efficacy of tamoxifen. , 1997, Oncology.

[6]  D. Rimm,et al.  Standardization of estrogen receptor measurement in breast cancer suggests false-negative results are a function of threshold intensity rather than percentage of positive cells. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  N. Otsu.  A threshold selection method from gray level histograms , 1979 .

[8]  Kevin W Eliceiri,et al.  NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.

[9]  Trevor Darrell,et al.  Fully Convolutional Networks for Semantic Segmentation , 2017, IEEE Transactions on Pattern Analysis and Machine Intelligence.

[10]  Nitish Srivastava,et al.  Dropout: a simple way to prevent neural networks from overfitting , 2014, J. Mach. Learn. Res..

[11]  Anthony Rhodes,et al.  American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. , 2010, Archives of pathology & laboratory medicine.

[12]  Sergey Ioffe,et al.  Batch Normalization: Accelerating Deep Network Training by Reducing Internal Covariate Shift , 2015, ICML.

[13]  Osborne Ck,et al.  Tamoxifen in the Treatment of Breast Cancer , 1998 .

[14]  Colin Raffel,et al.  Lasagne: First release. , 2015 .

[15]  John Salvatier,et al.  Theano: A Python framework for fast computation of mathematical expressions , 2016, ArXiv.

[16]  Alexander G. Fletcher,et al.  MultiCellDS: a community-developed standard for curating microenvironment-dependent multicellular data , 2016, bioRxiv.

[17]  C. Gomez-Fernandez,et al.  Immunohistochemistry of estrogen and progesterone receptors reconsidered: experience with 5,993 breast cancers. , 2005, American journal of clinical pathology.

[18]  Andrew H. Beck,et al.  Diagnostic Assessment of Deep Learning Algorithms for Detection of Lymph Node Metastases in Women With Breast Cancer , 2017, JAMA.

[19]  S. Legha,et al.  Tamoxifen in the treatment of breast cancer. , 1988, Annals of internal medicine.

[20]  M. Dowsett,et al.  Estrogen receptor: a never ending story? , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  Johannes E. Schindelin,et al.  Fiji: an open-source platform for biological-image analysis , 2012, Nature Methods.

[22]  D. Schaid,et al.  A double‐blind trial of tamoxifen plus prednisolone versus tamoxifen plus placebo in postmenopausal women with metastatic breast cancer. A collaborative trial of the north central cancer treatment group and mayo clinic , 1991, Cancer.

[23]  Brendan J. Frey,et al.  Classifying and segmenting microscopy images with deep multiple instance learning , 2015, Bioinform..

[24]  C. Stein,et al.  Making medicines safer--the need for an independent drug safety board. , 1998, The New England journal of medicine.

[25]  Breast cancer, version 3.2013: featured updates to the NCCN guidelines. , 2015, Journal of the National Comprehensive Cancer Network : JNCCN.